ATE382368T1 - Epitopen eines extrazellulären antigens - Google Patents
Epitopen eines extrazellulären antigensInfo
- Publication number
- ATE382368T1 ATE382368T1 AT98903550T AT98903550T ATE382368T1 AT E382368 T1 ATE382368 T1 AT E382368T1 AT 98903550 T AT98903550 T AT 98903550T AT 98903550 T AT98903550 T AT 98903550T AT E382368 T1 ATE382368 T1 AT E382368T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccines
- extracellular products
- majorly abundant
- stimulate
- amino acid
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 244000052769 pathogen Species 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 4
- 230000028993 immune response Effects 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 239000012678 infectious agent Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78653397A | 1997-01-21 | 1997-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382368T1 true ATE382368T1 (de) | 2008-01-15 |
Family
ID=25138865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98903550T ATE382368T1 (de) | 1997-01-21 | 1998-01-15 | Epitopen eines extrazellulären antigens |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1005365B1 (de) |
| JP (1) | JP2001512435A (de) |
| AT (1) | ATE382368T1 (de) |
| AU (1) | AU6029898A (de) |
| CA (1) | CA2278116A1 (de) |
| DE (1) | DE69838948T2 (de) |
| WO (1) | WO1998031388A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022320B1 (en) * | 1999-02-09 | 2006-04-04 | Powderject Vaccines, Inc. | Mycobacterium tuberculosis immunization |
| WO2000073345A2 (en) * | 1999-05-28 | 2000-12-07 | Promega Corporation | Antibodies specific for mycobacterial polypeptides and uses thereof |
| GB0003082D0 (en) * | 2000-02-10 | 2000-03-29 | Glaxo Group Ltd | Vaccine |
| GB0006693D0 (en) * | 2000-03-20 | 2000-05-10 | Glaxo Group Ltd | Vaccine |
| KR20080027973A (ko) * | 2000-06-22 | 2008-03-28 | 와이어쓰 홀딩스 코포레이션 | 보조제 배합물로서의 큐에스-21 및 아이엘-12 |
| EP1463526A4 (de) * | 2001-08-02 | 2006-08-30 | Univ New York | Früherkennung einer mycobakteriellen erkrankung unter verwendung von peptiden |
| EP2206514B1 (de) * | 2003-10-16 | 2014-01-08 | The Regents of The University of California | Rekombinante, intrazelluläre, immunogene Pathogenzusammensetzungen und Verwendungsverfahren |
| WO2006053871A2 (en) | 2004-11-16 | 2006-05-26 | Crucell Holland B.V. | Multivalent vaccines comprising recombinant viral vectors |
| WO2008140478A2 (en) * | 2006-11-01 | 2008-11-20 | Immport Therapeutics, Inc. | Compositions and methods for immunodominant antigens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5504005A (en) * | 1987-03-02 | 1996-04-02 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant mycobacterial vaccine |
| EP0419355B1 (de) * | 1989-09-19 | 2000-02-09 | N.V. Innogenetics S.A. | Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose |
| DE69435138D1 (de) * | 1993-11-23 | 2008-10-23 | Univ California | Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung |
| US5571515A (en) * | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| WO1996037219A1 (en) * | 1995-05-23 | 1996-11-28 | The Regents Of The University Of California | Abundant extracellular products and methods for their production and use |
-
1998
- 1998-01-15 CA CA002278116A patent/CA2278116A1/en not_active Abandoned
- 1998-01-15 JP JP53459398A patent/JP2001512435A/ja not_active Ceased
- 1998-01-15 AT AT98903550T patent/ATE382368T1/de not_active IP Right Cessation
- 1998-01-15 AU AU60298/98A patent/AU6029898A/en not_active Abandoned
- 1998-01-15 WO PCT/US1998/000942 patent/WO1998031388A1/en active IP Right Grant
- 1998-01-15 DE DE69838948T patent/DE69838948T2/de not_active Expired - Lifetime
- 1998-01-15 EP EP98903550A patent/EP1005365B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001512435A (ja) | 2001-08-21 |
| EP1005365B1 (de) | 2008-01-02 |
| CA2278116A1 (en) | 1998-07-23 |
| WO1998031388A1 (en) | 1998-07-23 |
| EP1005365A1 (de) | 2000-06-07 |
| AU6029898A (en) | 1998-08-07 |
| EP1005365A4 (de) | 2002-11-05 |
| DE69838948D1 (de) | 2008-02-14 |
| DE69838948T2 (de) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9408135A (pt) | Produtos extra-celulares abundantes e processos para sua produção e uso | |
| WO2002012281A3 (en) | Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| JP2014507146A5 (de) | ||
| WO2003070187A3 (en) | Fusion proteins of mycobacterium tuberculosis | |
| CA2523084A1 (en) | Tuberculosis vaccine with improved efficacy | |
| DE69838948D1 (de) | Epitopen eines extrazellulären antigens | |
| DE69736000D1 (de) | Identifizierung und klonierung eines mycobakterien antigens der einer heparin-bindenden hemaglutinin entspricht | |
| Whitlock et al. | Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge | |
| BR9608894A (pt) | Produtos extracelulares abundantes e processos para suas producões e usos | |
| WO2009074861A3 (en) | Improved vaccine | |
| WO2004103269A3 (en) | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia | |
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| WO2019143712A3 (en) | Induced common antibody response | |
| WO2020065349A8 (en) | Vaccines and methods | |
| WO2001063278A3 (en) | Antigenic fragments associated with stress-induced proteins and their use as vaccines | |
| WO2006091455A3 (en) | Molecular scaffolds for hiv-1 immunogens | |
| KR102451412B1 (ko) | 세포성, 체액성 면역 반응의 동시 유도 및 광범위한 방어능을 갖는 신규 면역 증강용 단백질 및 이를 포함하는 구제역 백신 조성물 | |
| MX9701103A (es) | Productos extracelulares abundantes y metodos para su produccion y uso. | |
| WO2000044392A3 (en) | Identification of specific differentially expressed mycobacterial antigens | |
| EP3485907B1 (de) | Behandlung und prophylaxe von k.-pneumoniae-infektionen | |
| WO2023094885A8 (en) | Antigenic determinants, protective immunity, serodiagnostic and multivalent subunits precision vaccine against sars-cov-2 | |
| Sonal Gupta et al. | A divalent vaccine candidate comprising BP26 and Omp25 against brucellosis. | |
| CN1579550A (zh) | 一种结核杆菌核酸疫苗 | |
| WO2023192971A3 (en) | Immunogens and vaccine compositions against hiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |